scholarly article | Q13442814 |
P356 | DOI | 10.1021/BI00443A002 |
P698 | PubMed publication ID | 2479412 |
P2093 | author name string | M Sugimoto | |
T Ogawa | |||
Y Igarashi | |||
S Fujita | |||
S Hakomori | |||
T Toyokuni | |||
B Dean | |||
E Racker | |||
K el-Ghendy | |||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6796-6800 | |
P577 | publication date | 1989-08-01 | |
P1433 | published in | Biochemistry | Q764876 |
P1476 | title | Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities | |
P478 | volume | 28 |
Q34593159 | "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets |
Q67904616 | 7 Use of synthetic amino acid polymers for assay of protein-tyrosine and protein-serine kinases |
Q55001442 | A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. |
Q36615136 | A new turning point in glycosphingolipid research |
Q43569605 | A novel plasmal conjugate to glycerol and psychosine ("glyceroplasmalopsychosine"): isolation and characterization from bovine brain white matter |
Q33861997 | A novel sphingosine kinase inhibitor induces autophagy in tumor cells |
Q27009351 | A review of ceramide analogs as potential anticancer agents |
Q36835151 | A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. |
Q44533963 | A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKCdelta: a preliminary note |
Q68202502 | Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells |
Q78428565 | B-5354a, b and c, New Sphingosine Kinase Inhibitors, Produced by a Marine Bacterium. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Determination. |
Q34955659 | Cationic glycosphingolipids in neuronal tissues and their possible biological significance |
Q37682095 | Cell regulation by sphingosine and more complex sphingolipids |
Q24653552 | Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate |
Q28483643 | Characterization of isoenzyme-selective inhibitors of human sphingosine kinases |
Q30417604 | Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors |
Q71907697 | Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro |
Q31803356 | Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages |
Q99241043 | Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer |
Q46885917 | Discrete influx events refill depleted Ca2+ stores in a chick retinal neuron |
Q41651579 | Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor |
Q28143356 | Effects of sphingosine and other sphingolipids on protein kinase C |
Q92684868 | Enantiomers of phospholipids and cholesterol: A key to decipher lipid-lipid interplay in membrane |
Q94141582 | Essential Role of Sphingosine Kinase 2 in the Regulation of Cargo Contents in the Exosomes from K562 Cells |
Q74044934 | F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete |
Q41969307 | Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture. |
Q79210653 | Glycosphingolipid-Induced Cell Signaling: Apoptosis |
Q36522848 | Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway |
Q71606754 | Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells |
Q40870274 | Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate |
Q41828412 | Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II. |
Q74440446 | Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide |
Q62733725 | Lack of costimulation by both sphingomyelinase and C2 ceramide in resting human T cells |
Q80801093 | Maternal alcohol consumption increases sphingosine levels in the brains of progeny mice |
Q34747143 | Mitochondria and ceramide: intertwined roles in regulation of apoptosis |
Q41653348 | Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol |
Q71699031 | N,N,N-trimethylsphingosine inhibits interleukin-1 beta-induced NF-kappa B activation and consequent E-selectin expression in human umbilical vein endothelial cells |
Q73966951 | N,N-dimethylsphingosine 1-phosphate activates human platelets |
Q67737588 | Oleoylamine and sphingosine stimulation of phosphatidylserine synthesis by LA-N-2 cells is protein kinase C independent |
Q40352532 | Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. |
Q48850074 | Patterns of endogenous gangliosides and metabolic processing of exogenous gangliosides in cerebellar granule cells during differentiation in culture |
Q35923305 | Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury |
Q33755206 | Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 |
Q78180232 | Phospholipid signalling pathways in Trypanosoma cruzi growth control |
Q37115205 | Protein kinase inhibitors: probes for the functions of protein phosphorylation |
Q44805681 | Psychosine cytotoxicity toward rat C6 glioma cells and the protective effects of phorbol ester and dimethylsulfoxide: Implications for therapy in Krabbe disease |
Q42795291 | Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver |
Q36553395 | Reminiscence of our research on membrane phospholipids in mammalian cells by using the novel technology |
Q34879183 | Roles of sphingosine 1-phosphate on tumorigenesis |
Q38869085 | S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis |
Q89587308 | S1P Signaling in the Tumor Microenvironment |
Q40670417 | Significance of ganglioside-mediated glycosignal transduction in neuronal differentiation and development. |
Q36967504 | Sphingolipid therapy in myocardial ischemia-reperfusion injury |
Q26829596 | Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis |
Q39095601 | Sphingolipids and glycerophospholipids - The "ying and yang" of lipotoxicity in metabolic diseases. |
Q33911965 | Sphingomyelin metabolites in vascular cell signaling and atherogenesis |
Q41547434 | Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. |
Q34121255 | Sphingosine 1-phosphate and cancer |
Q37249572 | Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness |
Q34233389 | Sphingosine 1-phosphate: synthesis and release |
Q35047156 | Sphingosine in apoptosis signaling |
Q41115281 | Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X(L) gene expression |
Q44896517 | Sphingosine inhibition and promotion of histamine release from isolated rat mast cells |
Q40562914 | Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts |
Q80145738 | Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase |
Q35563422 | Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion |
Q32064388 | Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors |
Q36235805 | Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction |
Q71034353 | Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells |
Q54342529 | Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. |
Q44144590 | Sphingosine-based liposome as DNA vector for intramuscular gene delivery. |
Q37571963 | Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert |
Q33941924 | Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance |
Q41656256 | Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines |
Q36559850 | Structure and function of glycosphingolipids and sphingolipids: recollections and future trends |
Q67464491 | Substrate-specific modulation of Src-mediated phosphorylation of Ras and caseins by sphingosines and other substrate modulators |
Q36970728 | Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression |
Q36868420 | Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors |
Q74640255 | The role of sphingolipids in the process of signal transduction |
Q35356324 | The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. |
Q24529582 | Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets |
Q73170835 | Use of circular dichroism for assigning stereochemistry of sphingosine and other long-chain bases |
Q33681203 | Use of sphingolipid analogs: benefits and risks |
Q47734379 | Vasoactive intestinal peptide induces both tyrosine hydroxylase activity and tetrahydrobiopterin biosynthesis in PC12 cells |
Search more.